Name | 4-[(3S,5S,10R,13R,14S,17S)-5,14-dihydroxy-3-[(2S,5R)-5-hydroxy-4-methoxy-6-methyl-oxan-2-yl]oxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one |
---|---|
Synonyms | periplocymarin |
Description | Periplocymarin, a cardiac glycoside isolated from Periploca sepium and Periploca graeca, is a potential anti-cancer compound[1][2]. |
---|---|
Related Catalog | |
In Vitro | Periplocymarin inhibits proliferation of PC3, U937, HCT-8, Bel-7402, BGC823, A549, and A2780 cell lines in vitro with IC50 values of 0.02-0.29 µM[2]. |
References |
Density | 1.27±0.1 g/cm3 (20 ºC 760 Torr) |
---|---|
Boiling Point | 690.9±55.0℃ at 760 mmHg |
Melting Point | 209-211 ºC |
Molecular Formula | C30H46O8 |
Molecular Weight | 534.68100 |
Exact Mass | 534.31900 |
PSA | 114.68000 |
LogP | 3.25430 |
Water Solubility | Very slightly soluble (0.43 g/L) (25 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|